Prof Michael Trauner presents: Emerging Role of the Hepatic Thyroid Hormone Pathway in the Pathophysiology of NASH as presented at EASL ‘23: Welcome and Introduction
Melody.education: Educational programs on Nonalcoholic Steatohepatitis (NASH) and Nonalcoholic Fatty Liver Disease (NAFLD)
00:00
Introduction to NASH: Unpacking the Global Epidemic and Therapeutic Needs
This chapter introduces a symposium on Nonalcoholic Steatohepatitis (NASH), outlining its relevance to liver health and metabolic disorders. It highlights discussions on the global prevalence of NASH, its links to obesity and type 2 diabetes, and the significance of liver fibrosis in disease progression.
Transcript
Play full episode
